Life Science Success – Détails, épisodes et analyse

In this episode of Life Science Success, we sit down with Paul Jaminet, Ph.D., founder and CEO of Angiex, Inc., to explore his groundbreaking work in developing Nuclear-Delivered Antibody-Drug Conjugates™ for cancer therapy. Paul shares his unique career journey from astrophysics to biotech, insights into leading innovative projects, and the challenges and triumphs of pushing the boundaries in cancer treatment. Don't miss this inspiring conversation with a visionary leader in the life sciences.

🔗 Learn more about Angiex, Inc.: https://angiex.com/ 📚 Discover Paul's book, "Perfect Health Diet": https://www.amazon.com/Perfect-Health... 🎙️ Subscribe for more insights from top industry leaders!

 

In this episode of Life Science Success, host Don interviews Paul Jaminet, founder and CEO of Angenex. Paul shares his unique journey from astrophysics to life sciences, detailing his groundbreaking work in developing nuclear delivered antibody drug conjugates targeting angiogenic tumor vasculature. Learn about the challenges, motivations, and scientific discoveries driving Angenex's success.   Sponsored by D3 Digital Media Marketing.     00:00 Introduction to Life Science Success Podcast 00:41 Sponsor Message from D3 Digital Media Marketing 01:23 Interview with Paul Jaminet: Founder and CEO of Angenex 01:45 Paul Jaminet's Journey from Astrophysics to Life Sciences 04:35 The Birth of Angenex and Its Groundbreaking Work 06:34 Challenges and Innovations in Developing Antibody Drug Conjugates 13:07 Phase One Clinical Trials and Progress 25:59 Leadership and Strategic Decisions in Biotech 37:10 Inspiration and Motivation Behind the Work 41:10 Concerns and Future Outlook 46:00 Conclusion and Final Thoughts

In this episode of Life Science Success, host Don interviews Artug Akar, Chief Operating Officer at Mercury, about his journey from mechanical engineering in Turkey to leading logistics transformation in the life sciences and healthcare sectors. Artug shares insights on the complexities and challenges of logistics, particularly cold chain management, during the pandemic. They also discuss Mercury's innovative digital transformation initiatives in logistics, such as AI and blockchain. Artug emphasizes the importance of trust, empathy, and leading by example in leadership, along with the benefits of growing and supporting team members. This episode is brought to you by D3 Digital Media Marketing.     00:00 Introduction to Life Science Success Podcast 00:33 Sponsor Message: D3 Digital Media Marketing 01:21 Interview with Artug Akar: Transforming Logistics in Life Sciences 01:53 Artug Akar's Background and Journey 03:30 Impact of the Pandemic on Mercury 06:08 Mercury's Role in Healthcare and Life Sciences 08:58 Challenges and Innovations in Cold Chain Logistics 12:16 Digital Transformation and Future Projects at Mercury 14:58 Leadership and Personal Insights from Artug Akar 25:50 Conclusion and Final Thoughts

Tushar Pandey is a distinguished expert in the Life Sciences industry, currently making significant strides at SimBioSys with his innovative approach to healthcare technology. His contributions have been pivotal in advancing medical solutions and improving patient outcomes.   In this episode of the Life Science Success Podcast, host Don interviews Tushar Pandey, CEO and Co-founder of SymBioSys, an innovative company reshaping precision cancer care. Tushar shares his intriguing journey from Uganda to the United States, his transition from engineering to healthcare, and the personal experiences that sparked his passion for precision medicine. The discussion highlights SymBioSys’ groundbreaking work in creating digital, cost-effective diagnostics to reduce uncertainty in cancer treatment. They explore the importance of addressing diversity in medical models, harnessing the power of AI, and solving challenges in drug development and patient care. Agendas like the company's comprehensive platform for early-stage breast cancer get a deep dive, showcasing how they bridge imaging, genomics, and patient-centered care for improved outcomes. This conversation is a rich mix of personal narrative, professional insights, and forward-thinking solutions in life sciences.     00:00 Introduction to Life Science Success Podcast 00:34 Sponsor Message from D3 Digital Media Marketing 01:25 Guest Introduction: Tushar Pandey 02:27 Tushar's Background and Journey 04:30 Early Career and Transition to Healthcare 06:01 Strata Decision Technology and Cost Optimization 07:57 Personal Impact of Cancer and Shift to Precision Medicine 08:54 Founding Symbiosis and Mission 11:04 Challenges and Innovations in Cancer Treatment 12:21 Symbiosis' Approach to Precision Medicine 14:04 Scientific and Emotional Theses 15:34 Digital Solutions and Global Scale 15:58 Breast Cancer Treatment and FDA Approval 18:05 Supporting Drug Developers and Dosing Regimens 19:30 Digital Orientation and Multi-Omics Data 20:24 Identifying Critical Data in Precision Medicine 20:50 Incorporating Diversity in Medical Models 23:49 Innovative Projects in Digital Health 25:07 The Role of Imaging in Precision Medicine 31:08 Challenges in Life Sciences and Overcoming Them 33:31 Leadership and Inspiration in Precision Medicine 37:28 Concerns and Future Directions in Healthcare 42:02 Conclusion and Final Thoughts  

In this episode of the Life Science Success Podcast we are joined by Stephanie Oestreich, Managing Director of the Myeloma Investment Fund, who has an extensive background in life sciences, leadership, and a unique perspective as a semi-professional violinist.

 

Stephanie shares her extensive background in life sciences and leadership, and discusses her passion for finding cures and treatments for devastating diseases like multiple myeloma. She provides insight into the innovative work of the Myeloma Investment Fund, their mission, and the process of fostering and investing in breakthrough therapies. Stephanie also touches on her teaching role at MIT and her unique perspective as a semi-professional violinist, drawing parallels between her musical and professional experiences.   00:00 Introduction to the Podcast 00:32 Sponsor Message: D3 Digital Media Marketing 01:21 Meet Stephanie Asterik 01:54 Stephanie's Journey in Life Sciences 03:48 The Complexity of Multiple Myeloma 04:51 Investing in Innovation 08:42 The Role of the Myeloma Investment Fund 11:03 Stephanie's Background and Leadership Lessons 15:02 The Art of Playing the Violin 18:33 Leadership Insights from Music 22:07 Final Thoughts and Reflections 27:55 Conclusion and Farewell  

In this episode of Life Science Success, host Don interviews Dr. Sam Clark, founder and CEO of Terran Biosciences. They talk about Dr. Clark's innovative approach to creating new neuropsychiatric therapeutics and how his personal experiences with mental illness inspired him to enter the biotech industry.   The episode also explores various breakthroughs at Terran, including their innovative work with prodrugs, anti-psychotics, and psychedelics, along with their unique, efficient team structure modeled after Silicon Valley tech companies. Additionally, they delve into the inspiration, challenges, and methodologies that drive Terran's mission to provide affordable and modern treatments for patients in need.     00:00 Introduction to Life Science Success Podcast 00:40 Sponsor Message from D3 Digital Media Marketing 01:21 Guest Introduction: Dr. Sam Clark 02:12 Dr. Clark's Journey into Biotech 04:15 Founding Terran Biosciences 07:13 Innovative Projects at Terran 13:00 Psychedelic Compounds and Patient Use 20:00 Overcoming Barriers in Drug Development 23:57 Leadership and Inspiration 31:09 Conclusion and Final Thoughts

In this episode of Life Science Success, host Don interviews Vance Lyon, an accomplished chemist with a four-decade career in the life sciences industry. Vance discusses his educational background, career journey, and key experiences.   The conversation also delves into the vital role of Davos Pharma in providing comprehensive services for biotech companies, including API production, formulation, and IND filings. Vance shares insights on leadership, his inspirations, and concerns, while reflecting on his contributions to significant pharmaceutical projects. Join us for an engaging discussion on life sciences, chemistry, and the intricacies of pharmaceutical development.     00:00 Introduction to Life Science Success Podcast 00:39 Sponsor Message: D3 Digital Media Marketing 01:22 Meet Vance Lyon: A Journey in Chemistry 02:27 Early Life and Education 07:22 Career Beginnings at Parish Chemical 11:08 Transition to Kemmerer Polytech 12:57 Joining Davos and Key Projects 16:06 Services Provided by Davos 27:34 Leadership and Personal Insights 35:52 Conclusion and Farewell

In this episode of the Life Science Success Podcast, host Don Davis, PhD, MBA, interviews Dr. William Chou of Passage Bio. Dr. Chou discusses his transition from a practicing physician to a leader in biotechnology, reflects on the profound patient relationships he misses, and shares insights into Passage Bio's work on gene therapy for neurodegenerative diseases like Frontotemporal Dementia (FTD). They delve into the progress of their Phase 1/2 clinical study, the urgency of developing treatments for genetic mutations, and the potential impact on patients and their families.   Learn about the most recent developments and how Passage Bio is working to give those suffering from these life-threatening conditions hope.   00:00 Welcome and Introduction 00:25 William's Journey into Life Sciences 01:30 The Emotional Impact of Leaving Clinical Practice 02:31 Overview of Passage Bio 02:52 Understanding Frontotemporal Dementia (FTD) 06:38 Current Progress and Future Prospects 10:04 The Urgency and Hope for FTD Treatments 11:37 Goals and Closing Remarks

In this episode of the Life Science Success Podcast, Don Davis PhD, MBA interviews Igor Fisch, founder of NewBiologix. Igor shares his journey from academia to entrepreneurship, highlighting his success with Selexis, a company he sold in 2017 that specialized in monoclonal antibodies. He discusses the challenges of gene therapy, specifically the high costs, and NewBiologix's innovative approach to making gene therapy more affordable. Igor also provides insights into the industry's future, emphasizing the significance of stable production platforms for viral particles.

00:00 Introduction and Welcome

00:15 Igor's Journey into Life Sciences

00:37 The Success of Selexis

00:56 Transition to Gene Therapy

03:32 Challenges in Gene Therapy

03:50 The Importance of Stable Platforms

05:11 The Role of Biotech Startups

05:57 Balancing Science and Business

06:51 Networking at BIO Conference

08:14 Future Vision for New Biologics

09:21 Conclusion and Farewell

In this episode of the Life Science Success Podcast, Dean Petkanas, co-founder of Kannalife Sciences, is interviewed at the Bio International Convention in San Diego. Dean shares his journey from investment banking in the 80s to founding Kannalife Sciences in 2009. He discusses the company's focus on developing cannabinoid-based drugs, specifically targeting chemotherapy-induced peripheral neuropathy. The conversation covers the challenges and opportunities in cannabinoid drug development, the importance of targeting specific types of pain, and the current state and future prospects of Kannalife Sciences. Dean also highlights the significance of partnering and collaboration in advancing novel therapeutics.       00:00 Welcome to the Life Science Success Podcast 00:20 Dean's Journey into Life Sciences 01:04 The Evolution of Kannalife Sciences 02:18 Challenges and Opportunities in Cannabinoid-Based Drugs 03:06 Understanding Pain and Neuropathy 06:08 Investment Insights and Market Trends 07:40 Kannalife Sciences's Current Focus and Future Prospects 10:02 The Importance of Partnering at Bio 11:02 Closing Remarks and Future Meetings  

In this episode of the Life Science Success Podcast, host Don interviews Sean Rothwell, CEO of Evoke Nano, about the company's groundbreaking work in developing EBQ218, a revolutionary nanoparticle-based pulmonary therapeutic. They discuss the efficacy of EBQ218 in treating cystic fibrosis and its potential as a broad-spectrum antibiotic against drug-resistant superbugs. Sean shares insights into the company's journey, their upcoming clinical trials, and the broader impact of their work on patient outcomes in the healthcare landscape. Tune in to learn how Evoke Bio is poised to make a significant difference in combating infectious diseases and improving lives.     00:00 Welcome and Introduction 00:09 First Impressions of BIO Conference 00:37 Sean's Background and Journey into Life Sciences 01:42 The Science Behind Evoke Nano 02:28 EBQ218: A Revolutionary Pulmonary Therapeutic 04:16 Challenges and Future Pathways 05:24 Investment and Partnership Opportunities 06:42 Broader Applications and Future Vision 08:16 Addressing Drug Resistance and Regulatory Pathways 18:48 Conclusion and Final Thoughts